Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Jobs News Biogen To Cut 1,000 Jobs As Focus Turns To Alzheimer S Drug Leqembi Launch is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Biogen Sees Potential in Combining Alzheimer’s and Obesity Drugs
If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ... Read More
Alzheimer’s Therapy Is Coming to the Home With FDA Approval of Injectable Eisai, Biogen Drug
The Eisai- and Biogen-partnered Alzheimer’s disease drug Leqembi has been available to date as an intravenous infusion that takes about an hour. Patients will soon have the option to choose an ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus